SHL Telemedicine Ltd. (NASDAQ:SHLT) Short Interest Up 50.0% in May

SHL Telemedicine Ltd. (NASDAQ:SHLT) saw a significant increase in short interest in May. As of May 31st, there was short interest totalling 300 shares, an increase of 50.0% from the May 15th total of 200 shares. Based on an average daily volume of 3,900 shares, the short-interest ratio is presently 0.1 days.

SHL Telemedicine Stock Down 6.8 %

SHL Telemedicine stock traded down $0.37 during mid-day trading on Friday, reaching $5.10. The company’s stock had a trading volume of 505 shares, compared to its average volume of 1,662. The company has a quick ratio of 2.10, a current ratio of 2.30 and a debt-to-equity ratio of 0.20. SHL Telemedicine has a 12 month low of $4.06 and a 12 month high of $12.40. The business’s 50 day simple moving average is $5.18 and its 200 day simple moving average is $6.50.

Wall Street Analysts Forecast Growth

Separately, Litchfield Hills Research reaffirmed a “buy” rating and set a $11.00 price target on shares of SHL Telemedicine in a research report on Thursday, March 14th.

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.